103 related articles for article (PubMed ID: 9459192)
1. The aromatase inhibitor letrozole in advanced breast cancer: effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels.
Bajetta E; Ferrari L; Celio L; Mariani L; Miceli R; Di Leo A; Zilembo N; Buzzoni R; Spagnoli I; Martinetti A; Bichisao E; Seregni E
J Steroid Biochem Mol Biol; 1997; 63(4-6):261-7. PubMed ID: 9459192
[TBL] [Abstract][Full Text] [Related]
2. Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients.
Ferrari L; Martinetti A; Zilembo N; Pozzi P; Buzzoni R; La Torre I; Gattinoni L; Catena L; Vitali M; Celio L; Seregni E; Bombardieri E; Bajetta E
J Steroid Biochem Mol Biol; 2002 Apr; 80(4-5):411-8. PubMed ID: 11983488
[TBL] [Abstract][Full Text] [Related]
3. The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty: a prospective study with a P450-aromatase inhibitor.
Wickman S; Saukkonen T; Dunkel L
Eur J Endocrinol; 2002 Mar; 146(3):339-46. PubMed ID: 11888840
[TBL] [Abstract][Full Text] [Related]
4. A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women.
Cigler T; Tu D; Yaffe MJ; Findlay B; Verma S; Johnston D; Richardson H; Hu H; Qi S; Goss PE
Breast Cancer Res Treat; 2010 Apr; 120(2):427-35. PubMed ID: 19967558
[TBL] [Abstract][Full Text] [Related]
5. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
Wickman S; Kajantie E; Dunkel L
J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
[TBL] [Abstract][Full Text] [Related]
6. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
Lintermans A; Vanderschueren D; Verhaeghe J; Van Asten K; Jans I; Van Herck E; Laenen A; Paridaens R; Billen J; Pauwels S; Vermeersch P; Wildiers H; Christiaens MR; Neven P
Eur J Cancer; 2014 Nov; 50(17):2925-31. PubMed ID: 25304297
[TBL] [Abstract][Full Text] [Related]
7. Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer.
Dowsett M; Pfister C; Johnston SR; Miles DW; Houston SJ; Verbeek JA; Gundacker H; Sioufi A; Smith IE
Clin Cancer Res; 1999 Sep; 5(9):2338-43. PubMed ID: 10499602
[TBL] [Abstract][Full Text] [Related]
8. The aromatase inhibitor letrozole increases epiphyseal growth plate height and tibial length in peripubertal male mice.
Eshet R; Maor G; Ben Ari T; Ben Eliezer M; Gat-Yablonski G; Phillip M
J Endocrinol; 2004 Jul; 182(1):165-72. PubMed ID: 15225141
[TBL] [Abstract][Full Text] [Related]
9. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
Cohen MH; Johnson JR; Li N; Chen G; Pazdur R
Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893
[TBL] [Abstract][Full Text] [Related]
10. Letrozole. A review of its use in postmenopausal women with advanced breast cancer.
Lamb HM; Adkins JC
Drugs; 1998 Dec; 56(6):1125-40. PubMed ID: 9878997
[TBL] [Abstract][Full Text] [Related]
11. Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer.
Arun B; Valero V; Liu D; Brewster A; Green M; Gutierrez-Barrera A; Akar U; Rivera E; Esteva FJ; Buzdar AU; Hortobagyi GN; Sneige N
Cancer Prev Res (Phila); 2012 Feb; 5(2):276-82. PubMed ID: 22102688
[TBL] [Abstract][Full Text] [Related]
12. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
Fabian CJ; Kimler BF; Zalles CM; Khan QJ; Mayo MS; Phillips TA; Simonsen M; Metheny T; Petroff BK
Breast Cancer Res Treat; 2007 Nov; 106(1):75-84. PubMed ID: 17221152
[TBL] [Abstract][Full Text] [Related]
13. Effects of decreased estradiol-17beta on the serum and anterior pituitary IGF-I system in pigs.
Hilleson-Gayne CK; Clapper JA
J Endocrinol; 2005 Dec; 187(3):369-78. PubMed ID: 16423816
[TBL] [Abstract][Full Text] [Related]
14. Influence of treatment with onapristone on the IGF-system in breast cancer patients.
Helle SI; Jonat W; Giurescu M; Ekse D; Holly JM; Lønning PE
J Steroid Biochem Mol Biol; 1998 Aug; 66(3):159-63. PubMed ID: 9719450
[TBL] [Abstract][Full Text] [Related]
15. Effects of conjugated equine estrogen vs. raloxifene on serum insulin-like growth factor-i and insulin-like growth factor binding protein-3: a 2-year, double-blind, placebo-controlled study.
Duschek EJ; de Valk-de Roo GW; Gooren LJ; Netelenbos C
Fertil Steril; 2004 Aug; 82(2):384-90. PubMed ID: 15302288
[TBL] [Abstract][Full Text] [Related]
16. In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer.
Dowsett M; Jones A; Johnston SR; Jacobs S; Trunet P; Smith IE
Clin Cancer Res; 1995 Dec; 1(12):1511-5. PubMed ID: 9815951
[TBL] [Abstract][Full Text] [Related]
17. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer.
Mouridsen H; Chaudri-Ross HA
Oncologist; 2004; 9(5):497-506. PubMed ID: 15477634
[TBL] [Abstract][Full Text] [Related]
19. Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?
Ferrari L; Bajetta E; Martinetti A; Celio L; Longarini R; La Torre I; Buzzoni R; Gattinoni L; Seregni E; Bombardieri E
Int J Oncol; 2003 May; 22(5):1081-9. PubMed ID: 12684675
[TBL] [Abstract][Full Text] [Related]
20. Decreased serum insulin-like growth factor-I in burn patients: relationship with serum insulin-like growth factor binding protein-3 proteolysis and the influence of lipid composition in nutritional support.
Abribat T; Nedelec B; Jobin N; Garrel DR
Crit Care Med; 2000 Jul; 28(7):2366-72. PubMed ID: 10921566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
